The Technical Analyst
Select Language :
VistaGen Therapeutics Inc [VTGN]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

VistaGen Therapeutics Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: SELL (auto-tracking)

VistaGen Therapeutics Inc is listed at the  Exchange

5.06% $4.57

America/New_York / 27 mar 2024 @ 16:00


VistaGen Therapeutics Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 123.51 mill
EPS: -2.96
P/E: -1.540
Earnings Date: Jun 25, 2024
SharesOutstanding: 27.03 mill
Avg Daily Volume: 0.272 mill
RATING 2024-03-27
B-
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Sell
Return On Asset: Neutral
DE: Sell
P/E: Strong Sell
Price To Book: Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -1.540 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.26x
Company: PE -1.540 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$1.981
(-56.65%) $-2.59
Date: 2024-03-28
Expected Trading Range (DAY)

$ 4.28 - 4.86

( +/- 6.28%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-04 Rotunno Mary L. Buy 12 500 Stock Option (Right to Buy)
2024-03-04 Gin Jerry B Buy 12 500 Stock Option (Right to Buy)
2024-03-04 Fitzpatrick Margaret M Buy 12 500 Stock Option (Right to Buy)
2024-03-04 Curley Joanne Buy 12 500 Stock Option (Right to Buy)
2024-03-04 Cunningham Ann Michelle Buy 12 500 Stock Option (Right to Buy)
INSIDER POWER
97.90
Last 94 transactions
Buy: 11 348 392 | Sell: 716 774

Forecast: 16:00 - $4.60

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $4.60
Forecast 2: 16:00 - $4.60
Forecast 3: 16:00 - $4.60
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $4.57 (5.06% )
Volume 0.246 mill
Avg. Vol. 0.272 mill
% of Avg. Vol 90.38 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for VistaGen Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for VistaGen Therapeutics Inc

RSI

Intraday RSI14 chart for VistaGen Therapeutics Inc

Last 10 Buy & Sell Signals For VTGN

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:28buy$4.94N/AActive
Profile picture for
            VistaGen Therapeutics Inc

VTGN

VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III development for the acute treatment of anxiety in adults with social anxiety disorder. Its PH94B product candidature also has potential to treat a range of anxiety disorders, including adjustment disorder with anxiety, postpartum anxiety, post-traumatic stress disorder, preprocedural anxiety, and panic disorders. The company's CNS pipeline also comprises PH10, a rapid-onset neuroactive nasal spray, which is in preparation for Phase 2B clinical development as a stand-alone treatment for major depressive disorder (MDD); and AV-101, an oral N-methyl-D-aspartate receptor antagonist, which is in development in combination with oral probenecid as a potential treatment of levodopa-induced dyskinesia, MDD, neuropathic pain, and suicidal ideation. It has contract research and development agreement with Cato Research Ltd.; license agreement with Pherin Pharmaceuticals, Inc.; and license and collaboration agreement with EverInsight Therapeutics Inc. VistaGen Therapeutics, Inc. was founded in 1998 and is headquartered in South San Francisco, California.

Last 10 Buy Signals

Date Signal @
FRONTUSDMar 28 - 08:37$1.261
ETHUPUSDMar 28 - 08:3834.73
XTZUSDMar 28 - 08:37$1.381
XAUTUSDMar 28 - 08:35$2 208.64
GASUSDMar 28 - 08:34$6.97
AAVEUSDMar 28 - 08:36$124.81
MASKUSDMar 28 - 08:35$5.22
GHSTUSDMar 28 - 08:35$1.632
GAFIUSDMar 28 - 08:349.30
KWENTAUSDMar 28 - 08:34110.22

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.